DR. PAUL AUSTIN FREDRICKSON, M.D.
Psychiatric at San Pablo Rd, Jacksonville, FL
License number
Florida ME74792
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Florida ME74792
Category
Psychiatric
Type
Psychiatry
Address
Address
4500 San Pablo Rd S, Jacksonville, FL 32224
Phone
(904) 953-2000
Personal information
See more information about PAUL AUSTIN FREDRICKSON at radaris.comName
Address
Phone
10754 Scott Mill Rd UNIT 1, Jacksonville, FL 32223
4800 Amelia Island Pkwy #C1, Fernandina, FL 32034
8155 SW 105Th Pl, Ocala, FL 34481
2854 Corinthian Ave, Jacksonville, FL 32210
2854 Corinthian Ave, Jacksonville, FL 32210
Professional information
Paul Austin Fredrickson, Jacksonville FL
Specialties:
Psychiatrist
Address:
4500 San Pablo Rd S, Jacksonville, FL 32224
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Sleep Medicine (Psychiatry and Neurology)
Captain At Fedex
Position:
Captain at FedEx
Location:
Jacksonville, Florida Area
Industry:
Package/Freight Delivery
Work:
FedEx
-
Captain
Dr. Paul A Fredrickson - MD (Doctor of Medicine)
Hospitals:
4205 Belfort Rd, Jacksonville 32216
Mayo Clinic
4500 San Pablo Rd, Jacksonville 32224
4205 Belfort Rd, Jacksonville 32216
Mayo Clinic
4500 San Pablo Rd, Jacksonville 32224
Mayo Clinic
4500 San Pablo Rd, Jacksonville 32224
4205 Belfort Rd, Jacksonville 32216
Mayo Clinic
4500 San Pablo Rd, Jacksonville 32224
Education:
Medical Schools
University Of Minnesota Medical School
Graduated: 1975
University Of Minnesota Medical School
Graduated: 1975
Paul Austin Fredrickson, Jacksonville FL
Specialties:
Psychiatry, Sleep Medicine, Sleep Medicine
Work:
Mayo Clinic hospital
4500 San Pablo Rd S, Jacksonville, FL 32224
4500 San Pablo Rd S, Jacksonville, FL 32224
Education:
University of Minnesota, Twin Cities (1975) Psychiatry
Treating The Effects Of Nicotine
US Patent:
2006018, Aug 24, 2006
Filed:
May 2, 2006
Appl. No.:
11/415570
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Paul Fredrickson - Jacksonville FL, US
Mona Boules - Jacksonville FL, US
Paul Fredrickson - Jacksonville FL, US
Mona Boules - Jacksonville FL, US
International Classification:
A61K 38/17, A61K 31/195
US Classification:
514012000, 514563000
Abstract:
The invention provides methods and materials for treating the effects of nicotine. In particular, the invention provides methods that involve administering a neurotensin receptor (NTR) agonist to a mammal that has been exposed to nicotine. The NTR agonist typically is administered in an amount effective to diminish or abolish the effects that nicotine has on the treated mammal. NTR agonists that can be used in methods of the invention include neurotensin (NT) polypeptide analogs such as NT69L. The invention also provides compositions containing an NTR agonist in combination with other agents used to help overcome nicotine effects such as sensitization and dependence. The compositions provided herein can be used to treat the effects of nicotine, including hyperactivity, hypothermia, respiratory distress, and hypertension.
Treating The Effect Of Nicotine
US Patent:
7087575, Aug 8, 2006
Filed:
Jul 18, 2002
Appl. No.:
10/198697
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Paul Fredrickson - Jacksonville FL, US
Mona Boules - Jacksonville FL, US
Paul Fredrickson - Jacksonville FL, US
Mona Boules - Jacksonville FL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 1/37, A61K 38/00, A61K 38/04, A01K 37/18
US Classification:
514 14, 435 23, 514 2, 514813, 530300, 530327
Abstract:
The invention provides methods and materials for treating the effects of nicotine. In particular, the invention provides methods that involve administering a neurotensin receptor (NTR) agonist to a mammal that has been exposed to nicotine. The NTR agonist typically is administered in an amount effective to diminish or abolish the effects that nicotine has on the treated mammal. NTR agonists that can be used in methods of the invention include neurotensin (NT) polypeptide analogs such as NT69L. The invention also provides compositions containing an NTR agonist in combination with other agents used to help overcome nicotine effects such as sensitization and dependence. The compositions provided herein can be used to treat the effects of nicotine, including hyperactivity, hypothermia, respiratory distress, and hypertension.